当前位置:首页 - 行情中心 - 迪哲医药-U(688192) - 财务分析

迪哲医药-U

(688192)

  

流通市值:52.32亿  总市值:176.69亿
流通股本:1.23亿   总股本:4.16亿

迪哲医药-U(688192)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润-2.24亿元,每股收益-0.54元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益69659.27万元,未分配利润-273779.98万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产155223.83万元,负债85564.56万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入81,318,56091,288,64040,102,4000
营业总成本338,128,124.11,252,634,286.09896,482,852.81536,264,657.75
营业利润-224,234,890.87-1,107,611,930.58-828,916,026.19-514,199,537.56
利润总额-224,234,890.87-1,107,611,930.58-828,916,026.19-514,199,537.56
净利润-224,234,890.87-1,107,713,253.26-828,949,591.21-514,252,601.51
其他综合收益----
综合收益总额-224,234,890.87-1,107,713,253.26-828,949,591.21-514,252,601.51
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计978,932,665.1910,361,387.231,084,851,232.361,135,420,457.12
非流动资产合计573,305,593.89586,017,180.21588,491,691.64603,812,708.85
资产总计1,552,238,258.991,496,378,567.441,673,342,9241,739,233,165.97
流动负债合计544,709,818.61448,435,584.97526,802,099.42318,783,281.71
非流动负债合计310,935,774.01199,315,566.6764,267,239.1973,877,684.4
负债合计855,645,592.62647,751,151.64591,069,338.61392,660,966.11
归属于母公司股东权益合计696,592,666.37848,627,415.81,082,273,585.391,346,572,199.86
股东权益合计696,592,666.37848,627,415.81,082,273,585.391,346,572,199.86
负债和股东权益合计1,552,238,258.991,496,378,567.441,673,342,9241,739,233,165.97
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计125,113,639.21102,797,666.1326,305,772.1925,195,319.46
经营活动现金流出小计251,185,527.991,070,680,617.26695,438,348.16465,521,440.75
经营活动产生的现金流量净额-126,071,888.78-967,882,951.13-669,132,575.97-440,326,121.29
投资活动现金流入小计1,027,230,950.134,380,127,803.723,468,191,094.882,563,032,720.64
投资活动现金流出小计1,087,674,912.143,768,938,122.113,025,188,087.272,228,171,038.69
投资活动产生的现金流量净额-60,443,962.01611,189,681.61443,003,007.61334,861,681.95
筹资活动现金流入小计267,454,705340,320,656.42201,168,873.9380,897,096.06
筹资活动现金流出小计59,886,850.2832,071,550.7525,266,720.1513,403,642.12
筹资活动产生的现金流量净额207,567,854.72308,249,105.67175,902,153.7867,493,453.94
汇率变动对现金及现金等价物的影响59,274.65971,238.14-2,048,972.6-2,287,093.81
现金及现金等价物净增加额21,111,278.58-47,472,925.71-52,276,387.18-40,258,079.21
期末现金及现金等价物余额95,037,852.5473,926,573.9669,123,112.4981,141,420.46
最新报告期:2024-05-07
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
兴业证券孙媛媛,杨希成,黄翰漾-2.25-1.40-0.122024-05-07
浙商证券孙建,郭双喜-2.25-1.56-0.942024-05-06
中金公司屈潇逸-2.78-1.81--2024-05-01
浙商证券孙建,郭双喜-2.18-1.24--2024-03-27
中信证券陈竹,韩世通-1.56-1.26--2024-02-29
TOP↑